Total Payments
$282,186
2024 Payments
$27,361
Companies
22
Transactions
572
Medicare Patients
28,570
Medicare Billing
$3.2M
Payment Breakdown by Category
Other$196,731 (69.7%)
Travel$24,578 (8.7%)
Research$23,567 (8.4%)
Consulting$20,928 (7.4%)
Food & Beverage$16,283 (5.8%)
Gifts$99.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $143,728 | 55 | 50.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $31,525 | 13 | 11.2% |
| Travel and Lodging | $24,578 | 107 | 8.7% |
| Unspecified | $23,567 | 7 | 8.4% |
| Consulting Fee | $20,928 | 13 | 7.4% |
| Food and Beverage | $16,283 | 366 | 5.8% |
| Acquisitions | $13,903 | 1 | 4.9% |
| Honoraria | $7,200 | 8 | 2.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $375.00 | 1 | 0.1% |
| Gift | $99.99 | 1 | 0.0% |
Payments by Type
General
$258,620
565 transactions
Research
$23,567
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aerie Pharmaceuticals, Inc. | $69,724 | 96 | $0 (2021) |
| ABBVIE INC. | $48,997 | 58 | $0 (2024) |
| Allergan, Inc. | $48,459 | 164 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $38,204 | 53 | $0 (2021) |
| Glaukos Corporation | $34,612 | 103 | $0 (2024) |
| Bausch Health US, LLC | $23,250 | 5 | $0 (2019) |
| Alcon Vision LLC | $15,847 | 23 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $962.19 | 25 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $507.29 | 6 | $0 (2024) |
| Ivantis, Inc | $466.44 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,361 | 46 | ABBVIE INC. ($14,018) |
| 2023 | $23,736 | 59 | ABBVIE INC. ($20,843) |
| 2022 | $29,456 | 44 | Alcon Vision LLC ($14,402) |
| 2021 | $32,333 | 66 | Aerie Pharmaceuticals, Inc. ($13,904) |
| 2020 | $16,994 | 38 | Aerie Pharmaceuticals, Inc. ($7,200) |
| 2019 | $73,628 | 138 | Aerie Pharmaceuticals, Inc. ($29,798) |
| 2018 | $71,372 | 132 | Aerie Pharmaceuticals, Inc. ($18,822) |
| 2017 | $7,306 | 49 | Allergan Inc. ($6,570) |
All Payment Transactions
572 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,725.00 | General |
| Category: EYE CARE | ||||||
| 12/02/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,025.00 | General |
| Category: EYE CARE | ||||||
| 11/14/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Travel and Lodging | In-kind items and services | $1,151.25 | General |
| Category: EYE CARE | ||||||
| 11/14/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $109.89 | General |
| Category: EYE CARE | ||||||
| 10/30/2024 | Glaukos Corporation | iDose (Device) | Consulting Fee | Cash or cash equivalent | $6,400.00 | General |
| Category: Glaucoma | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.31 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/22/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $20.30 | General |
| Category: Glaucoma | ||||||
| 10/02/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $118.54 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Glaukos Corporation | iDose (Device) | Travel and Lodging | Cash or cash equivalent | $2,058.39 | General |
| Category: Glaucoma | ||||||
| 09/18/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $264.18 | General |
| Category: Glaucoma | ||||||
| 09/18/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Ophthalmology | ||||||
| 09/09/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Ophthalmology | ||||||
| 08/29/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $26.05 | General |
| Category: Glaucoma | ||||||
| 08/19/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $27.51 | General |
| Category: Glaucoma | ||||||
| 07/12/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Glaucoma | ||||||
| 07/09/2024 | Nova Eye, Inc. | — | Food and Beverage | In-kind items and services | $127.64 | General |
| 07/08/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Ophthalmology | ||||||
| 06/17/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $26.67 | General |
| Category: Glaucoma | ||||||
| 06/14/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: EYE CARE | ||||||
| 06/03/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,725.00 | General |
| Category: EYE CARE | ||||||
| 05/21/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: EYE CARE | ||||||
| 05/14/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO, VYZULTA | Food and Beverage | In-kind items and services | $39.28 | General |
| Category: Ophthalmology | ||||||
| 05/13/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $20.70 | General |
| Category: Glaucoma | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-Masked, Active-Controlled, Parallel Group, Multi-Center Bioequivalence Study of the Generic Brinzolamide 1 Ophthalmic Suspension Compared to Reference Listed Drug Azopt Brinzolamide Ophthalmic Suspension 1 in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension. | Bausch Health US, LLC | $13,000 | 3 |
| A RANDOMIZED, DOUBLE-MASKED, ACTIVE-CONTROLLED, PARALLEL GROUP, MULTI-CENTER BIOEQUIVELENCE STUDY OF THE GENERIC BRINZOLAMIDE 1 OPHTHALMIC SUSPENSION COMPARED TO BRANDED BRINZOLAMIDE 1 OPHTHALMIC SUSPENSION AZOPT IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION | Bausch Health US, LLC | $10,250 | 2 |
| Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 | Glaukos Corporation | $311.07 | 1 |
| XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma Gold-Standard Pathway Study GPS | Allergan Inc. | $5.43 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 6,716 | 8,215 | $2.6M | $787,976 |
| 2022 | 25 | 7,455 | 9,204 | $2.6M | $843,622 |
| 2021 | 26 | 7,669 | 9,589 | $2.6M | $845,097 |
| 2020 | 23 | 6,730 | 8,362 | $2.3M | $745,620 |
Total Patients
28,570
Total Services
35,370
Medicare Billing
$3.2M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 184 | 320 | $361,560 | $128,466 | 35.5% |
| 66991 | Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | Facility | 2023 | 119 | 203 | $271,255 | $101,521 | 37.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,001 | 1,059 | $275,389 | $91,955 | 33.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 780 | 1,352 | $246,064 | $79,516 | 32.3% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 304 | 307 | $219,960 | $79,351 | 36.1% |
| 66174 | Dilation of fluid outflow drainage within eye | Facility | 2023 | 120 | 210 | $418,950 | $55,926 | 13.3% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 137 | 138 | $117,369 | $41,899 | 35.7% |
| 66183 | Insertion of eye fluid drainage device | Facility | 2023 | 34 | 34 | $73,644 | $26,947 | 36.6% |
| 92250 | Photography of the retina | Office | 2023 | 833 | 845 | $87,035 | $22,724 | 26.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 445 | 468 | $60,840 | $19,549 | 32.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 384 | 808 | $56,557 | $17,422 | 30.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 169 | 169 | $52,221 | $15,442 | 29.6% |
| 66761 | Creation of eye fluid drainage tracts in iris using a laser, per session | Facility | 2023 | 55 | 56 | $41,080 | $15,227 | 37.1% |
| 66172 | Creation of eye fluid drainage tract for treatment of glaucoma with previous scarring | Facility | 2023 | 14 | 14 | $35,070 | $12,715 | 36.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 470 | 474 | $36,498 | $11,764 | 32.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 523 | 576 | $32,832 | $11,737 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 119 | $27,132 | $11,719 | 43.2% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 13 | 16 | $26,352 | $9,719 | 36.9% |
| 66250 | Revision or repair of operative wound of eye | Office | 2023 | 13 | 15 | $23,277 | $7,666 | 32.9% |
| 66250 | Revision or repair of operative wound of eye | Facility | 2023 | 13 | 14 | $16,394 | $5,562 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $11,832 | $4,150 | 35.1% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 333 | 337 | $11,121 | $3,738 | 33.6% |
| 68320 | Repair of eyelid lining with graft from external eye | Facility | 2023 | 16 | 16 | $18,160 | $3,390 | 18.7% |
| 92134 | Imaging of retina | Office | 2023 | 113 | 118 | $10,030 | $3,164 | 31.5% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 360 | 360 | $9,360 | $2,931 | 31.3% |
About Dr. Joshua Kim, MD
Dr. Joshua Kim, MD is a Ophthalmology healthcare provider based in Venice, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740391952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Kim, MD has received a total of $282,186 in payments from pharmaceutical and medical device companies, with $27,361 received in 2024. These payments were reported across 572 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($143,728).
As a Medicare-enrolled provider, Kim has provided services to 28,570 Medicare beneficiaries, totaling 35,370 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Venice, FL
- Active Since 08/31/2006
- Last Updated 04/19/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1740391952
Products in Payments
- LUMIGAN (Drug) $48,417
- Rhopressa (Drug) $42,422
- VYZULTA (Drug) $38,395
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $32,235
- rocklatan (Drug) $15,083
- HYDRUS Microstent (Device) $14,312
- BRINZOLAMIDE (Drug) $13,000
- iDose (Device) $12,566
- XEN (Device) $10,948
- AZOPT (Drug) $10,250
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $9,272
- iStent inject Trabecular Micro-Bypass Stent System (Device) $8,741
- Rocklatan (Drug) $6,218
- rhopressa (Drug) $6,004
- COMBIGAN (Drug) $3,261
- DURYSTA (Drug) $1,521
- iStent Trabecular Micro-Bypass Stent System (Device) $1,474
- Simbrinza (Drug) $1,140
- ALPHAGAN P (Drug) $509.86
- Tecnis Multifocal Family of 1-piece IOLS (Device) $311.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Venice
John Fezza, Md, MD
Ophthalmology — Payments: $3.4M
Ophthalmology $3.4M
P Dee Stephenson, M.d., P.a, M.D., P.A
Ophthalmology — Payments: $595,281
Ophthalmology $595,281
Dr. Priya Mathews, M.d, M.D
Ophthalmology — Payments: $234,923
Ophthalmology $234,923
Dr. Joaquin De Rojas, M.d, M.D
Ophthalmology — Payments: $106,363
Ophthalmology $106,363
Steven Kane, M.d, M.D
Ophthalmology — Payments: $64,773
Ophthalmology $64,773
Dr. David Shoemaker, Md, MD
Ophthalmology — Payments: $8,077
Ophthalmology $8,077